Neurological Disorder Drugs Market Size to Surpass US$ 88.07 billion by 2031 - Growth Plus Reports
January 18, 2024 05:30 ET
|
Growth Plus Reports
Pune, Jan. 18, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Neurological Disorder Drugs Market is expected to clock US$ 88.07 billion by 2031...
Neurological Disorder Drugs Market Size to Surpass US$ 88.07 Billion by 2031 - Growth Plus Reports
July 02, 2023 23:30 ET
|
Growth Plus Reports
Newark, New Castle, USA, July 02, 2023 (GLOBE NEWSWIRE) -- A recent report by Growth Plus Reports estimated the global neurological disorder drugs market to be worth US$ 60.1 billion in 2022. From...
Neurological Disorder Drugs Market to Expand Notably, Foresees Fairfield Market Research
March 06, 2023 13:12 ET
|
Fairfield Consultancy Services OPC Pvt Ltd
London, March 06, 2023 (GLOBE NEWSWIRE) -- Neurological disorders have been among the leading causes of mortality worldwide. Although a majority of neurological conditions predominantly tends to...
AI in Drug Discovery Market to Rise at 36.1% CAGR during Forecast Period: TMR Study
October 03, 2022 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – By 2031, the AI in drug discovery market size is estimated to surpass value of US$ 10.93...
Neurological Disorder Drugs Market to Reach Tremendous Value of US$ 125.60 Billion during Forecast 2022-2029, Size, Share, Industry Growth, Competitive Analysis and Trends forecast
September 19, 2022 13:54 ET
|
Data Bridge Market Research
NEW YORK, Sept. 19, 2022 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market research's database of 350 pages, titled as “Global Neurological Disorder Drugs Market”...
Neurological Disorder Drugs Market to Expand with Rise in Focus of Players on Development of 3D CNS Organoids, States TMR Study
April 25, 2022 11:30 ET
|
Transparency Market Research
Increase in number of patients suffering from disorders, such as multiple sclerosis, Parkinson’s disease, cerebrovascular diseases, Alzheimer’s disease, and epilepsy is bolstering the market ALBANY,...
Neurological Disorder Drugs Market Report Up to 2031: Visiongain Research Inc
December 14, 2021 09:19 ET
|
Visiongain Ltd
Visiongain has published a new report on Neurological Disorder Drugs Market Report 2021-2031: Forecasts By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic,...